Miriam Donaldson

Miriam Donaldson is a transformational leader with over 25 years of experience in the pharmaceutical and biotech industries.1 She previously worked at Novartis, where she held leadership roles in organizational transformation and human resources, specifically leading digital commercial transformation.2 Donaldson recently closed her chapter at Novartis after a long career that began as an MBA intern at NIBR (Novartis Institutes for BioMedical Research).2 She is now associated with Cellcolabs, having joined their board in October 2024.3 Donaldson has an educational background from Harvard Business School1 and remains actively involved with Harvard alumni activities.4

Career Highlights

• Novartis: Held various leadership positions, including roles in organizational transformation and HR for digital commercial transformation.2
• Cellcolabs: Joined the board in October 2024, focusing on high-quality stem cell therapies.3
• Industry Experience: Over 25 years in pharma and biotech sectors.1

Education and Alumni Involvement

• Graduated from Harvard Business School.1
• Actively participates in Harvard alumni activities and elections.4

Donaldson is known for her expertise in reimagining medicine and has been involved in various unique and exciting opportunities throughout her career.2 She continues to engage with healthcare and industry-related topics, sharing insights on platforms like LinkedIn.5